What is Johnson & Johnson's MEDTECH — amortization?

Johnson & Johnson (JNJ) reported MEDTECH — amortization of $500M in Q1 2026.

How has Johnson & Johnson's MEDTECH — amortization changed year-over-year?

Johnson & Johnson's MEDTECH — amortization decreased by 0.0% year-over-year, from $500M to $500M.

What does MEDTECH — amortization mean?

This represents the periodic expense recognized for the allocation of the cost of intangible assets, such as patents and acquired technology, over their useful lives within the medical technology segment. It reflects the non-cash consumption of intellectual property value. Monitoring this helps investors understand the impact of past acquisitions on current earnings.

Johnson & Johnson JNJ MEDTECH — Amortization

Other segment segments

Innovative Medicine

$800M+33.3%

Similar metrics at other companies

MEIMedical — Intangible Amortization

$0—

TTECTtec Digital — Intangible Amortization

$7.73M-6.4%

NOVTMedical Solutions — Intangible Amortization

$3.66M+16.2%

INVTechnology — Depreciation and Amortization Expense:

$5.67M+2.2%

KNMedTech & Specialty Audio — D&A

$2.13M+2.4%

IEXHealth & Science Technologies — Intangible Amortization

$27.1M+10.2%

Other financials

Income statement

See full

Revenue$24.1B+9.9%

Gross profit$16.0B+9.8%

Operating income$6.3B+2.3%

Net income$5.2B-52.4%

EPS (diluted)$2.14-52.9%

Balance sheet

See full

Cash & equivalents$21.7B-43.6%

Total debt$55.0B+5.2%

Total equity$81.2B+3.9%

Total assets$200.89B+3.7%

Cash flow

See full

Operating cash flow$2.5B-39.8%

CapEx$1.0B+31.9%

Free cash flow$1.5B-56.6%

Valuation

See full

Market cap$623.71B+66.9%

Enterprise value$657.01B+61.9%

P/E29.6×+13.2×

P/S6.5×+2.3×

Profitability

See full

Gross margin67.8%-0.5pp

Operating margin26.4%+2.8pp

Net margin21.8%-2.6pp

FCF margin18.5%-4.3pp

Returns & leverage

See full

Return on equity26.4%-3.0pp

Debt / equity0.7×0.0×

Current ratio1×-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentForAmortization.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's medtech — amortization.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Johnson & Johnson's MEDTECH — amortization?: Johnson & Johnson (JNJ) reported MEDTECH — amortization of $500M in Q1 2026.
How has Johnson & Johnson's MEDTECH — amortization changed year-over-year?: Johnson & Johnson's MEDTECH — amortization decreased by 0.0% year-over-year, from $500M to $500M.
What does MEDTECH — amortization mean?: This represents the periodic expense recognized for the allocation of the cost of intangible assets, such as patents and acquired technology, over their useful lives within the medical technology segment. It reflects the non-cash consumption of intellectual property value. Monitoring this helps investors understand the impact of past acquisitions on current earnings.